Metropolitan Life Insurance CO United Therapeutics Corp Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$166.16 - $213.96 $1.34 Million - $1.72 Million
-8,040 Closed
0 $0
Q4 2021

Jun 21, 2023
BUY
$184.32 - $216.08 $1.48 Million - $1.74 Million
8,040 New
8,040 $1.74 Million
Q4 2021

Mar 30, 2023
BUY
$184.32 - $216.08 $135,659 - $159,034
736 Added 10.08%
8,040 $1.74 Million
Q4 2021

Feb 15, 2022
BUY
$184.32 - $216.08 $135,659 - $159,034
736 Added 10.08%
8,040 $1.74 Million
Q3 2021

Jun 21, 2023
BUY
$179.86 - $214.88 $1.47 Million - $1.76 Million
8,182 New
8,182 $1.51 Million
Q3 2021

Mar 30, 2023
SELL
$179.86 - $214.88 $206,299 - $246,467
-1,147 Reduced 13.57%
7,304 $1.35 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $206,299 - $246,467
-1,147 Reduced 13.57%
7,304 $1.35 Million
Q2 2021

Jun 21, 2023
BUY
$170.47 - $211.93 $1.44 Million - $1.79 Million
8,451 New
8,451 $1.52 Million
Q2 2021

Mar 30, 2023
BUY
$170.47 - $211.93 $158,366 - $196,882
929 Added 12.35%
8,451 $1.52 Million
Q2 2021

Aug 16, 2021
BUY
$170.47 - $211.93 $1.44 Million - $1.79 Million
8,443 Added 105537.5%
8,451 $1.52 Million
Q1 2021

Jun 26, 2023
BUY
$153.94 - $174.85 $1.29 Million - $1.47 Million
8,401 New
8,401 $1.41 Billion
Q1 2021

Mar 30, 2023
SELL
$153.94 - $174.85 $65,732 - $74,660
-427 Reduced 5.37%
7,522 $1.26 Million
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $1.22 Million - $1.39 Million
-7,941 Reduced 99.9%
8 $1.26 Million
Q4 2020

Jun 22, 2023
BUY
$101.87 - $151.79 $809,764 - $1.21 Million
7,949 New
7,949 $1.21 Million
Q4 2020

Mar 30, 2023
SELL
$101.87 - $151.79 $21,087 - $31,420
-207 Reduced 2.54%
7,949 $1.21 Million
Q4 2020

Feb 16, 2021
SELL
$101.87 - $151.79 $21,087 - $31,420
-207 Reduced 2.54%
7,949 $1.21 Million
Q3 2020

Jun 26, 2023
BUY
$99.9 - $121.13 $814,784 - $987,936
8,156 New
8,156 $823,000
Q3 2020

Mar 30, 2023
SELL
$99.9 - $121.13 $36,463 - $44,212
-365 Reduced 4.28%
8,156 $823,000
Q3 2020

Nov 13, 2020
SELL
$99.9 - $121.13 $36,463 - $44,212
-365 Reduced 4.28%
8,156 $824,000
Q2 2020

Jun 26, 2023
BUY
$92.74 - $125.82 $790,237 - $1.07 Million
8,521 New
8,521 $1.03 Million
Q2 2020

Mar 30, 2023
SELL
$92.74 - $125.82 $291,945 - $396,081
-3,148 Reduced 26.98%
8,521 $1.03 Million
Q2 2020

Aug 14, 2020
SELL
$92.74 - $125.82 $291,945 - $396,081
-3,148 Reduced 26.98%
8,521 $1.03 Million
Q1 2020

Jul 12, 2023
BUY
$79.39 - $115.35 $926,401 - $1.35 Million
11,669 New
11,669 $1.11 Million
Q1 2020

Mar 30, 2023
SELL
$79.39 - $115.35 $50,333 - $73,131
-634 Reduced 5.15%
11,669 $1.11 Million
Q1 2020

May 15, 2020
SELL
$79.39 - $115.35 $50,333 - $73,131
-634 Reduced 5.15%
11,669 $1.11 Million
Q4 2019

Jul 12, 2023
BUY
$78.31 - $95.34 $963,447 - $1.17 Million
12,303 New
12,303 $1.08 Million
Q4 2019

Mar 30, 2023
BUY
$78.31 - $95.34 $6,421 - $7,817
82 Added 0.67%
12,303 $1.08 Million
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $6,421 - $7,817
82 Added 0.67%
12,303 $1.08 Million
Q3 2019

Jul 12, 2023
BUY
$74.85 - $85.99 $914,741 - $1.05 Million
12,221 New
12,221 $974,000
Q3 2019

Mar 30, 2023
SELL
$74.85 - $85.99 $21,182 - $24,335
-283 Reduced 2.26%
12,221 $974,000
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $21,182 - $24,335
-283 Reduced 2.26%
12,221 $975,000
Q2 2019

Jul 12, 2023
BUY
$76.06 - $120.81 $951,054 - $1.51 Million
12,504 New
12,504 $976,000
Q2 2019

Mar 30, 2023
BUY
$76.06 - $120.81 $1,977 - $3,141
26 Added 0.21%
12,504 $976,000
Q2 2019

Aug 14, 2019
BUY
$76.06 - $120.81 $1,977 - $3,141
26 Added 0.21%
12,504 $976,000
Q1 2019

Jul 13, 2023
BUY
$107.15 - $126.84 $1.34 Million - $1.58 Million
12,478 New
12,478 $1.46 Million
Q1 2019

Mar 30, 2023
BUY
$107.15 - $126.84 $1.34 Million - $1.58 Million
12,478 New
12,478 $1.46 Million
Q1 2019

May 16, 2019
BUY
$107.15 - $126.84 $439,850 - $520,678
4,105 Added 49.03%
12,478 $1.46 Million
Q1 2019

May 15, 2019
SELL
$107.15 - $126.84 $438,136 - $518,648
-4,089 Reduced 32.81%
8,373 $336,000
Q4 2018

Jul 13, 2023
BUY
$101.4 - $128.73 $1.26 Million - $1.6 Million
12,462 New
12,462 $1.36 Million
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $4,563 - $5,792
45 Added 0.36%
12,462 $1.36 Million
Q3 2018

Jul 13, 2023
BUY
$113.81 - $129.46 $1.41 Million - $1.61 Million
12,417 New
12,417 $1.59 Billion
Q3 2018

Nov 14, 2018
SELL
$113.81 - $129.46 $14,226 - $16,182
-125 Reduced 1.0%
12,417 $1.59 Million
Q2 2018

Aug 15, 2018
BUY
$101.14 - $118.31 $7,282 - $8,518
72 Added 0.58%
12,542 $0
Q1 2018

May 15, 2018
BUY
$107.21 - $151.94 $10,613 - $15,042
99 Added 0.8%
12,470 $0
Q4 2017

Feb 15, 2018
SELL
$118.58 - $151.28 $3.38 Million - $4.31 Million
-28,485 Reduced 69.72%
12,371 $1.83 Million
Q3 2017

Nov 14, 2017
SELL
$114.6 - $136.81 $176,713 - $210,961
-1,542 Reduced 3.64%
40,856 $4.79 Million
Q2 2017

Aug 14, 2017
BUY
N/A
42,398
42,398 $5.5 Million

Others Institutions Holding UTHR

# of Institutions
679
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email